Mylan N.V. (NASDAQ, TASE: MYL) today announced that its abbreviated new drug application (ANDA) for fluticasone propionate 100, 250, 500 mcg and salmeterol 50 mcg inhalation powder has been accepted ...
Advair is used to treat asthma and chronic obstructive pulmonary disease. The Association for Accessible Medicines is voicing strong opposition that the proposed U.S.-Mexico-Canada trade agreement ...
GlaxoSmithKline gains 2.7 percent after Novartis hands back U.S. rights to a drug widely thought to be a generic copy of its blockbuster Advair, reducing the threat of cheap copies of the lung drug in ...
1. Wixela Inhub is Mylan’s generic version of Advair, an asthma treatment made by GlaxoSmithKline. 2. Tosymra is a sumatriptan nasal spray used to treat migraines in adults. 3. Imbruvica in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results